FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 339:704-705 September 3, 1998 Number 10 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Simons, F. E. R. PubMed Citation

To the Editor: Simons et al. (Dec. 4 issue)¹ report that inhaled beclomethasone is somewhat more effective than salmeterol in controlling symptoms of asthma in children and that beclomethasone retards children's growth, whereas salmeterol does not. Additional analyses of the data are needed to clarify the growth-impairing effects of beclomethasone.

Despite randomization at base line, the groups were not well balanced with respect to height. The mean height was 138.5 cm in the placebo group, 140.0 cm in the beclomethasone group, and 134.6 cm in the salmeterol group, and these differences were significant (P=0.04 for the overall comparison among groups . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.